共 119 条
- [1] Adler DJ(1990)The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis Am J Gastroenterol 85 717-722
- [2] Korelitz BI(1995)Azathioprine and 6-mercaptopurine in Crohn disease: a meta-analysis Ann Intern Med 123 132-142
- [3] Pearson DC(1996)A review of immune modifier therapy for inflammatory bowel disease: azathioprine, 6-mercaptopurine, cyclosporine, and methotrexate Am J Gastroenterol 91 423-433
- [4] May GR(1998)Safety of azathioprine and 6-mercaptopurine in pediatric patients with inflammatory bowel disease Gastroenterology 115 813-821
- [5] Fick GH(1989)6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity Ann Intern Med 111 641-649
- [6] Sandborn WJ(1993)Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience Gut 34 1081-1085
- [7] Kirschner BS(1992)High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample J Chromatogr 583 83-90
- [8] Present DH(1998)Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC Clin Chem 44 551-555
- [9] Meltzer SJ(1990)A reversed phase high performance liquid chromatography approach in determining total red blood cell concentrations of 6-thioguanine, 6-mercaptopurine, methylthioguanine, and methylmercaptopurine in a patient receiving thiopurine therapy Biomed Chromatogr 4 47-51
- [10] Krumholz MP(1996)6-Mercaptopurine metabolism in Crohn’s disease: correlation with efficacy and toxicity Gut 39 401-406